Cisplatin with rt

Author: fthc

August undefined, 2024

WebAug 29, 2012 · Cisplatin + RT for Triple Negative Breast Cancer The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. ClinicalTrials.gov Identifier: NCT01674842 Recruitment Status : … WebApr 1, 2024 · Cisplatin Chemoradiotherapy vs Radiotherapy in FIGO Stage IIIB Squamous Cell Carcinoma of the Uterine Cervix: A Randomized …

Combined Chemoradiotherapy Regimens of Paclitaxel and …

WebWeekly cisplatin with radiotherapy for locally advanced head and neck squamous cell carcinoma Our study shows that a median cumulative dose of 200 mg/m2 cisplatin can be safely administered using a weekly regimen to patients treated with concomitant RT (CFRT or ART). WebFeb 11, 2024 · Cisplatin was given either at a dose of 100 mg/m 2 every 3 weeks (day 1, 22, and 43) during RT (University Hospital Basel) to a planned cumulative dose of 300 mg/m 2 or at a dose of 40 mg/m 2 (University Hospital Zurich) or 50 mg/m 2 (Cantonal Hospital Winterthur) weekly for 6 or 7 infusions (days 1, 8, 15, 22, 29, 36, and 43) to a planned … inz variation of travel conditions

Safety and efficacy of concurrent carboplatin plus radiotherapy for ...

WebFeb 16, 2016 · Cisplatin is standardly dosed in a three-weekly schedule of 100 mg/m 2 (total dose 300 mg/m 2) combined with standard RT [3,6,7,9,10]. However, a high-dose cisplatin regimen is associated with major toxic side effects (myelosuppression, neurotoxicity, ototoxicity, and nephrotoxicity). WebSep 21, 2016 · RTOG 88-08 used a chemoradiotherapy regimen of cisplatin 100 mg/m 2 on days 1 and 29 and vinblastine 5 mg/m 2 once per week for 5 consecutive weeks beginning on day 1, followed by TRT to a total dose of 60 Gy in … WebBackground and purpose: In patients with head-and-neck cancer treated with chemoradiotherapy (CRT), a cisplatin-based regimen is often used. Several treatment schedules are accepted with a cumulative cisplatin dose of 200 mg/m (2) (CisCD200) given during radiotherapy. on scroll counter codepen

Concomitant Weekly Cisplatin and Radiotherapy for Head and …

CISplatin (40mg/m2) Weekly with Radiotherapy (RT)

WebIn addition, no significant difference in overall survival was seen in the matched cohorts. ChemoRT with either cisplatin or carboplatin was superior to RT alone and RT with concurrent cetuximab. In the multivariable model, the adjusted hazard ratio of CSM for carboplatin relative to cisplatin was 1.01 (95% CI, 0.79–1.28; P=.94). WebOct 14, 2024 · Addition of concomitant cisplatin to RT improves outcome, with an absolute gain in overall survival (OS) of 6.5% at 5 years. 3 Cisplatin administered intravenously at a dose of 100 mg/m 2 every third week is … inz view of anzscoWebNov 1, 2007 · All patients received pelvic external beam radiotherapy (EBRT) concurrently with weekly intravenous Cis-platinum chemotherapy (40 mg/m (2)) followed by brachytherapy (BT). The median dose of EBRT was 4500 cGy … inz welcoming communities

"WebCisplatin is believed to augment the effects of radiation by inhibiting the repair of radiation-induced sublethal damage and by sensitizing hypoxic cells to radiation. 9,30 Because of … " - Cisplatin with rt

Cisplatin with rt

Radiation Oncology/Head & Neck/Concurrent Chemo-RT

WebThe oral vinorelbine-cisplatin combination with concurrent RT is feasible and has a favorable risk-benefit ratio in stage IIIA/IIIB NSCLC. Oral vinorelbine and cisplatin with … WebSep 18, 2024 · NCBI Bookshelf

Did you know?

WebIntroduction: The aim of this multicenter phase II trial was to evaluate the combination of oral vinorelbine and cisplatin with radiotherapy (RT) after cisplatin-docetaxel induction chemotherapy (CT) in patients with locally advanced non-small cell lung cancer (NSCLC). Patients and methods: Patients with previously untreated, inoperable, histologically or … WebApr 14, 2024 · Among the extracellular vesicles, apoptotic bodies (ABs) are only formed during the apoptosis and perform a relevant role in the pathogenesis of different diseases. Recently, it has been demonstrated that ABs from human renal proximal tubular HK-2 cells, either induced by cisplatin or by UV light, can lead to further apoptotic death in …

WebMay 27, 2024 · However, when cetuximab-based chemoradiotherapy was compared with the combination of RT and cisplatin (a crosslinking cytotoxic chemotherapy), OS, PFS, and LRC were significantly worse in unselected patients with HPV-positive oropharyngeal cancer who received cetuximab rather than cisplatin ( 4, 5 ). WebSep 10, 2024 · 16 pts. Dose finding study. RT to 70 Gy, 3 pts with hyperfractionated RT to 76.8 Gy. Cetuximab given with loading dose of 400-500 mg/m2 then weekly infusions of …

WebSep 15, 2024 · DESCRIPTION. Cisplatin Injection (cisplatin injection (cisplatin (cisplatin injection) injection) ) is a sterile aqueous solution, available in 50, 100 and 200 mL … WebThe beneficial effects of cisplatin, which is the most widely used agent for CCRT in CC patients, whether alone or in combination with other drugs, were not independently …

WebCisplatin is a chemotherapy drug used to treat testicular, ovarian, bladder, head and neck, lung and cervical cancer. It may also be used to treat other cancers. It is best to read this …

WebSep 21, 2016 · Cisplatin was discontinued for grade 3 or 4 peripheral neuropathy. During those weeks in which the patient did not receive CT, RT was continued as long as the WBC count was ≥ 2000/μL and the platelet count was ≥ 50,000/μL. RT was interrupted for a period of no greater than 1 week for grade 3 or 4 diarrhea. onscroll counterWebRadiotherapy (RT) was given concurrently with cisplatin and etoposide. G-CSF was given as primary or secondary prophylaxis or as a therapeutic measure during an episode of febrile neutropenia according to local protocols. Common terminology criteria for adverse events (CTCAE) v3.0 was used to record toxicity. ... inz working holidayWebDec 13, 2016 · This outcome is to confirm the safety and tolerability of escalating doses of BMX-001 in conjunction with RT and concurrent cisplatin in a cohort of newly diagnosed patients with locally advanced head and neck cancers. Each dose will be reported separately. Incidence Radiation-induced Mucositis by Clinician Scoring [ Time Frame: 6 … on scroll change header backgroundWebWeekly cisplatin with radiotherapy for locally advanced head and neck squamous cell carcinoma. Our study shows that a median cumulative dose of 200 mg/m2 … onscrollenddragWebAug 28, 2024 · The investigators primary hypothesis is that LD weekly cisplatin 40 mg/m² is associated with reduced frequency of severe hearing loss and improved hearing-related QOL when compared to conventional HD cisplatin 100 mg/m² days 1, 22 & 43 (control arm) in LASCCHN patients treated with CRT. inzy df groundWebCISplatin L01XA01 REFERENCES: 1. Rose P, Bundy BN, Watkins EB, et al. Concurrent CISplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med. 1999;340(15):1144-1153. 2. Cisplatin, Radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage 1B cervical carcinoma. on scroll end eventWebIntroduction. Radiotherapy (RT) is the most common type of curative and palliative treatment for all cancer patients, including breast cancer patients. 1,2 Worldwide, breast cancers had totaled up to 2 million new cancer cases in the year 2024, which was approximately closed to the number of lung cancers and followed by colorectal, prostate and stomach cancers. … onscrollending outsystems